youtube_live
Q3 2026 earnings • in 3 days
See detailschevron_right
GL:NYSE
Globe Life Inc
$167.89
arrow_downward
-0.52%(-0.88) 1D
Oct 19, 1:51:04 PM GMT-4 · USD
search
All symbols
No data
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for GL...
Open
$168.33
High
$169.52
Low
$167.17
Mkt. cap
12.92B
Avg. vol.
423.01K
Volume
150.18K
Dividend
0.79%
Quarterly dividend
$0.33
Ex-dividend date
Oct 5, 2026
P/E ratio
11.15
52-wk high
$191.55
52-wk low
$127.84
EPS
$15.06
Beta
0.44
Shares outstanding
76.85M
No. of employees
4K
Open
$168.33
High
$169.52
Low
$167.17
Mkt. cap
12.92B
Avg. vol.
423.01K
Volume
150.18K
Dividend
0.79%
Quarterly dividend
$0.33
Ex-dividend date
Oct 5, 2026
P/E ratio
11.15
52-wk high
$191.55
52-wk low
$127.84
EPS
$15.06
Beta
0.44
Shares outstanding
76.85M
No. of employees
4K
News stories
From web sources and news partners
Zacks
·
5 hours ago
What's in the Cards for Globe Life This Earnings Season?
TradingView
·
6 hours ago
What's in the Cards for Globe Life This Earnings Season?
Yahoo Finance
·
7 hours ago
Globe Life Inc. Announces Third Quarter 2026 Earnings Release and Conference Call
InsuranceNewsNet
·
2 days ago
Ellsworth Advisors LLC Buys New Shares in Globe Life Inc. $GL
Profile
Globe Life Inc. is an American financial services holding company listed on the New York Stock Exchange which operates through its wholly owned subsidiaries providing life insurance, annuity, and supplemental health insurance products. The company is based in McKinney, Texas. Wikipedia
About Globe Life Inc
CEOFrank M Svoboda | J. Matthew Darden
Employees3.7K
Founded1900
HeadquartersMcKinney, Texas, United States
SectorInsurance
Websitehome.globelifeinsurance.com
Analyst ratings
Based on 8 analysts giving stock ratings to GL in the past 3 months
Strong buy
Buy
7
Hold
1
Sell
0
12-month forecast
Based on 8 Wall Street analysts offering 12 month price targets for GL in the last 3 months.
Highest
Current $167.89
$225.00 (+34.02%)
Average
$196.88 (+17.27%)
Lowest
$185.00 (+10.19%)
Analyst | Recommendation | Action | Price target | Projected | Date |
|---|---|---|---|---|---|
Pablo Singzon J.P. Morgan | Buy | Reiterated | $195.00 | +16.1% | 10/15/2026 |
Wesley Carmichael Wells Fargo | Buy | Maintained | $191.00 | +13.8% | 10/12/2026 |
Bob Huang Morgan Stanley | Buy | Reiterated | $197.00 | +17.3% | 10/05/2026 |
Menno Hulshof TD Cowen | Buy | Maintained | $225.00 | +34% | 08/31/2026 |
Andrew Kligerman TD Cowen | Buy | Maintained | $225.00 | +34% | 08/31/2026 |
Michael Zaremski BMO Capital | Hold | Maintained | $192.00 | +14.4% | 07/28/2026 |
Mark Hughes Truist Financial | Buy | Maintained | $185.00 | +10.2% | 07/24/2026 |
Paul Newsome Piper Sandler | Buy | Maintained | $200.00 | +19.1% | 07/24/2026 |
Ryan Krueger KBW | Buy | Maintained | $190.00 | +13.2% | 07/24/2026 |
Elyse Greenspan Wells Fargo | Buy | Maintained | $190.00 | +13.2% | 07/24/2026 |
Suneet Kamath Jefferies | Hold | Maintained | $166.00 | -1.1% | 07/10/2026 |
Randy Binner Texas Capital Securities | Buy | Maintained | $170.00 | +1.3% | 05/27/2026 |
Thomas Gallagher Evercore ISI | Hold | Maintained | $157.00 | -6.5% | 04/24/2026 |
Jack Matten BMO Capital | Hold | Maintained | $148.00 | -11.8% | 04/22/2026 |
John Barnidge Piper Sandler | Buy | Maintained | $167.00 | -0.5% | 04/02/2026 |
Jimmy Bhullar J.P. Morgan | Buy | Maintained | $181.00 | +7.8% | 03/05/2026 |
Next call in 3 days
Thu, Oct 22, 5:00 PM
Fiscal period
Q3 2026
- Normalized EPS / Est. (USD)
- GAAP EPS / Est. (USD)
- / $4.89
Revenue / Est. (USD)
- / 1.61B
Fiscal Q3 2026 earnings call
youtube_liveWaiting for the earnings call
At a glance: upcoming earnings
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
- Quarterly
- Annual
All values in USD | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
Revenue | 1.51B | 1.52B | 1.56B | 1.60B |
Cost of goods sold | 888.19M | 1.03B | 1.08B | 1.09B |
Cost of revenue | 888.19M | 1.03B | 1.08B | 1.09B |
Research and development expenses | - | - | - | - |
Total research and development expenses | - | - | - | - |
Selling, general, and admin expenses | - | 7.10M | - | - |
Operating expense | 108.97M | 117.18M | 111.51M | 112.99M |
Total operating expenses | 997.16M | 1.15B | 1.19B | 1.21B |
Operating income | 515.82M | 368.39M | 370.35M | 394.20M |
Other non operating income | - | - | - | - |
EBT including unusual items | 477.10M | 329.49M | 334.13M | 354.89M |
EBT excluding unusual items | 479.69M | 333.18M | 336.35M | 358.15M |
Income tax expense | 89.26M | 63.41M | 63.61M | 67.14M |
Effective tax rate | 18.71% | 19.24% | 19.04% | 18.92% |
Other operating expenses | 94.37M | 97.39M | 97.91M | 96.02M |
Net income | 387.84M | 266.08M | 270.53M | 287.75M |
Net profit margin | 25.63% | 17.51% | 17.35% | 17.99% |
Earnings per share | 4.81 | 3.39 | 3.43 | 3.61 |
Interest and investment income | - | - | - | - |
Interest expense | -36.13M | -35.21M | -34.00M | -36.05M |
Net interest expenses | -36.13M | -35.21M | -34.00M | -36.05M |
Depreciation and amortization charges | - | - | - | - |
EBITDA | 522.58M | 375.89M | 377.85M | 401.70M |
Gain or loss from assets sale | - | - | - | - |
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider | Position | Type | Date | Shares | Amount |
|---|---|---|---|---|---|
Page 1